JOURNAL ARTICLE
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. F Roila, A Molassiotis, J Herrstedt, M Aapro, R J Gralla, E Bruera, R A Clark-Snow, L L Dupuis, L H Einhorn, P Feyer, P J Hesketh, K Jordan, I Olver, B L Rapoport, J Roscoe, C H Ruhlmann, D Walsh, D Warr, M van der Wetering No abstract text is available yet for this article.
Full text links
Group 7 Search Heart failure treatment Papers Topics Collections Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents- sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducing September 1, 2017: JAMA Cardiology Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininine Jul, 2011: European Journal of Heart Failure Randomized Controlled Trial Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. Revie w Get seemless 1-tap access through your institution/university Read mobile app
Get app Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy .